Form 4: Achieve Life Sciences Officer Jerry Wan Reports Stock Transactions

Jerry Wan, Principal Accounting Officer of Achieve Life Sciences, reports the acquisition and disposal of common stock related to the settlement of performance restricted stock units (PRSUs).

Summary

• On April 19, 2024, Jerry Wan, Principal Accounting Officer of Achieve Life Sciences, engaged in transactions involving the company's common stock.
• Wan acquired 5,625 shares of common stock upon the settlement of performance restricted stock units (PRSUs) at a price of $0.
• Simultaneously, 2,250 shares were withheld by the issuer to cover tax liabilities associated with the PRSU settlement at a price of $4.51.
• Following these transactions, Wan directly owns 9,807 shares of Achieve Life Sciences common stock.
• The reported transactions also involve PRSUs, where each unit represents the right to receive one share of common stock upon settlement, with vesting tied to performance-based milestones.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by an officer. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

Form 4 filings are standard disclosures required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock. This allows investors to track insider sentiment and potential alignment with company performance.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the actions of company insiders.

Key Dates